BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21076037)

  • 21. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
    Lewis TL; Cao D; Lu H; Mans RA; Su YR; Jungbauer L; Linton MF; Fazio S; LaDu MJ; Li L
    J Biol Chem; 2010 Nov; 285(47):36958-68. PubMed ID: 20847045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
    Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    Eugenín J; Vecchiola A; Murgas P; Arroyo P; Cornejo F; von Bernhardi R
    J Alzheimers Dis; 2016 May; 53(3):857-73. PubMed ID: 27258416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.
    Terwel D; Steffensen KR; Verghese PB; Kummer MP; Gustafsson JÅ; Holtzman DM; Heneka MT
    J Neurosci; 2011 May; 31(19):7049-59. PubMed ID: 21562267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
    Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
    Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load.
    Oroszi T; Geerts E; Rajadhyaksha R; Nyakas C; van Heuvelen MJG; van der Zee EA
    Behav Brain Funct; 2023 Mar; 19(1):5. PubMed ID: 36941713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice.
    Chakrabarty P; Ceballos-Diaz C; Beccard A; Janus C; Dickson D; Golde TE; Das P
    J Immunol; 2010 May; 184(9):5333-43. PubMed ID: 20368278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
    Ameen-Ali KE; Simpson JE; Wharton SB; Heath PR; Sharp PS; Brezzo G; Berwick J
    J Alzheimers Dis; 2019; 68(2):609-624. PubMed ID: 30814360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
    Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
    J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.